NR4A1 and breast carcinoma: No association was observed in patients receiving prescriptions for hormone therapy (a proxy for oestrogen receptor positivity) and previous investigators have not seen differences in the association between aspirin exposure and breast cancer progression by hormone receptor status [4,6].